Skip to content

Eloxx Pharmaceuticals Inc Sustainability Reports

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel RNA-modulating drug candidates. The company mainly develops small-molecule product candidates designed to treat rare and ultra-rare premature stop codon diseases.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 549300UB28QGWJMFFA11

No reports are currently available in our catalogue.